v3.5.0.2
CONDENSED BALANCE SHEETS - USD ($)
$ in Thousands
Sep. 30, 2016
Dec. 31, 2015
Current assets:    
Cash and cash equivalents $ 330 $ 2,465
Prepaid expenses 131 114
Total current assets 461 2,579
Office equipment, net of accumulated depreciation of $0 and $27 4 12
Intangible assets, net of accumulated amortization of $140 and $128 72 84
Other assets 3 3
Total assets 540 2,678
Current liabilities:    
Accounts payable 1,097 977
Accrued expenses 2,726 2,432
Derivative liability 756 1,177
Total current liabilities 4,579 4,586
Total liabilities 4,579 4,586
Commitments and contingencies
Stockholders’ deficit:    
Convertible preferred stock, par value $.0001 per share; 30,000,000 shares authorized, 1,853 issued and outstanding, respectively 0 0
Common stock, par value $0.0001 per share; 150,000,000 shares authorized, 1,392,079 shares issued and outstanding, respectively 1 1
Additional paid-in capital 43,426 43,356
Accumulated deficit (47,466) (45,265)
Total stockholders’ deficit (4,039) (1,908)
Total liabilities and stockholders’ deficit $ 540 $ 2,678

Source

v3.5.0.2
CONDENSED STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2016
Sep. 30, 2015
Sep. 30, 2016
Sep. 30, 2015
Research and development $ 379 $ 459 $ 1,025 $ 1,885
General and administrative 509 915 1,600 2,864
Total operating expenses 888 1,374 2,625 4,749
Loss from operations (888) (1,374) (2,625) (4,749)
Gain (loss) on change in fair value of derivative liability (334) 0 421 0
Interest income (expense), net 1 1 3 0
Loss before provision for income taxes (1,221) (1,373) (2,201) (4,749)
Provision for income taxes 0 0 0 0
Net loss $ (1,221) $ (1,373) $ (2,201) $ (4,749)
Net loss per common share, basic and diluted $ (0.88) $ (1.12) $ (1.58) $ (4.12)
Weighted average shares outstanding 1,392,079 1,228,542 1,392,079 1,152,308

Source

v3.5.0.2
CONDENSED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2016
Sep. 30, 2015
Cash flows from operating activities:    
Net loss $ (2,201) $ (4,749)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 16 15
Stock-based compensation 70 265
Loss on sale of assets 4 0
Gain on change in fair value of derivative liability (421) 0
Decrease (increase) in operating assets:    
Prepaid expenses (17) 70
Increase (decrease) in operating liabilities:    
Accounts payable and accrued expenses 414 779
Cash used in operating activities (2,135) (3,620)
Cash flows from investing activities:    
Proceeds from sale of assets 4  
Acquisition of office equipment (4) (4)
Cash used in investing activities 0 (4)
Cash flows from financing activities:    
Proceeds from sale of common stock and warrants sold 0 2,514
Cost of common stock and warrants sold 0 (253)
Proceeds from exercise of warrants 0 287
Cash provided by financing activities 0 2,548
Net decrease in cash (2,135) (1,076)
Cash and cash equivalents, beginning of period 2,465 2,316
Cash and cash equivalents, end of period $ 330 $ 1,240

Source